COPD Therapeutics

The objective of COPD therapeutics is to improve a patient's practical status and quality by protecting optimal lung function, enhancing indications, and keeping the recurrence of COPD exacerbations. At present, no medicines aside from lung transplantation have been appeared to significantly improve lung capacity or diminishing mortality; however, oxygen treatment and smoking cessation may decrease mortality. Once the diagnosis of COPD is established, it is essential to educate the patient about the disorder and to enable their dynamic interest for treatment. Bronchodilators are the establishment of any COPD treatment regimen. They work by enlarging aviation routes, accordingly diminishing airsac protection. Pulmonary Conferences provides a podium to bring forward the novel therapies for pulmonology.

 

  • Smoking Cessation
  • Corticosteroids
  • Oxygen Therapy
  • Pulmonary Rehabilitation

Related Conference of COPD Therapeutics

April 22-23, 2019

World Congress on Advancements in Tuberculosis and Lung Diseases

| Radisson Hotel Narita | Tokyo, Japan

COPD Therapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in